University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2

Phase 1

Completed

Conditions: Malaria

Interventions: Biological: ChAdOx1 LS2
Biological: MVA LS2

First Posted Date: 2017-06-29

Last Posted Date: 2018-06-13

Lead Sponsor: University of Oxford

Target Recruit Count: 18

Registration Number: NCT03203421

Locations: 🇬🇧
CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom

Effects of Dietary Intervention and Surgery on NAFLD (Non-Alcoholic Fatty Liver Disease)

Not Applicable

Completed

Conditions: Non-Alcoholic Fatty Liver Disease
Non Alcoholic Fatty Liver
Bariatric Surgery Candidate
Obesity, Morbid

Interventions: Procedure: Sleeve Gastrectomy (SG) surgery
Procedure: Roux-en-Y Gastric Bypass (RYGB) surgery

First Posted Date: 2017-06-14

Last Posted Date: 2023-05-10

Lead Sponsor: University of Oxford

Target Recruit Count: 41

Registration Number: NCT03186859

Locations: 🇬🇧
University of Oxford, Oxford, United Kingdom

Vascularised Sentinel Skin Flaps to Detect Rejection in Pancreas Transplantation

Phase 1

Conditions: Pancreas Transplant Rejection

Interventions: Other: Sentinel skin flap

First Posted Date: 2017-06-12

Last Posted Date: 2019-04-17

Lead Sponsor: University of Oxford

Target Recruit Count: 20

Registration Number: NCT03183258

Locations: 🇬🇧
Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

Repurposing Anti-TNF for Treating Dupuytren's Disease

Phase 2

Completed

Conditions: Dupuytren's Disease

Interventions: Drug: Saline
Drug: Adalimumab

First Posted Date: 2017-06-08

Last Posted Date: 2024-06-28

Lead Sponsor: University of Oxford

Target Recruit Count: 140

Registration Number: NCT03180957

Locations: 🇬🇧
NHS Lothian, Edinburgh, United Kingdom
🇬🇧
Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
🇳🇱
The University Medical Centre, Groningen, Netherlands

Fluorescent Imaging & Methylene Blue: Ureter Study

Phase 2

Completed

Conditions: Ureteric Injury
Surgery
Surgery--Complications

Interventions: Drug: Methylene Blue

First Posted Date: 2017-06-06

Last Posted Date: 2017-06-06

Lead Sponsor: University of Oxford

Target Recruit Count: 50

Registration Number: NCT03177070

Locations: 🇬🇧
Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom

Post Static Cold Storage Normothermic Machine Liver Perfusion

Phase 1

Conditions: Liver Transplantation

First Posted Date: 2017-06-05

Last Posted Date: 2017-06-05

Lead Sponsor: University of Oxford

Target Recruit Count: 30

Registration Number: NCT03176433

Locations: 🇬🇧
King's College Hospital, London, United Kingdom
🇬🇧
Royal Free Hospital, London, United Kingdom
🇬🇧
Addenbrooke's Hospital, Cambridge, United Kingdom

First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition

Phase 3

Conditions: Antibiotic Resistance
Malnutrition Severe
Antibiotic Toxicity

Interventions: Drug: Benzyl penicillin
Other: Placebo
Drug: Ceftriaxone
Drug: Metronidazole
Drug: Gentamicin

First Posted Date: 2017-06-02

Last Posted Date: 2020-05-19

Lead Sponsor: University of Oxford

Target Recruit Count: 2000

Registration Number: NCT03174236

Locations: 🇰🇪
Mbagathi Hospital, Nairobi, Kenya
🇰🇪
Coast General Hospital - Study site, Mombasa, Kenya
🇰🇪
Mbagathi District Hospital, Nairobi, Kenya

and more 4 locations

Anemia Pregnancy Outcome on the Thai-Myanmar Border

Completed

Conditions: Anemia Pregnancy

First Posted Date: 2017-06-02

Last Posted Date: 2018-08-31

Lead Sponsor: University of Oxford

Target Recruit Count: 13520

Registration Number: NCT03174652

Locations: 🇹🇭
Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand

Pembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

Phase 1

Terminated

Conditions: Non-muscle Invasive Bladder Cancer (NMIBC)

Interventions: Drug: Pembrolizumab

First Posted Date: 2017-05-25

Last Posted Date: 2020-07-31

Lead Sponsor: University of Oxford

Target Recruit Count: 6

Registration Number: NCT03167151

Locations: 🇬🇧
University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom
🇬🇧
Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom
🇬🇧
Royal Surrey County Hospital NHS Foundation Trust, Guildford, Surrey, United Kingdom

The Effects of Prebiotics on Cognitive Functioning and Weight Gain in Psychosis

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Dietary Supplement: prebiotics
Dietary Supplement: Maltodextrin

First Posted Date: 2017-05-15

Last Posted Date: 2019-04-18

Lead Sponsor: University of Oxford

Target Recruit Count: 39

Registration Number: NCT03153046

Locations: 🇬🇧
Warneford Hospital, Oxford, Oxfordshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy